| | | | | | | | | | | | | | | | |
| |
| Issue Date FY: 2025 ( Subtotal = $98,932 ) |
| 2025 | 2024 | NDRI-USA INC | 31 W 34TH ST | NEW YORK | NY | 10001-3009 | NEW YORK | USA | R01DA054990 | Community Developed Technology-Based Messaging to Increase SARS-CoV-2 Vaccine Uptake Among People Who Inject Drugs | 001 | 4 | NIH | 10/10/2024 | $98,932 |
|
| Issue Date FY: 2024 ( Subtotal = $2,302,067 ) |
| 2024 | 2024 | NDRI-USA INC | 31 W 34TH ST | NEW YORK | NY | 10001-3009 | NEW YORK | USA | R01DA058016 | The Impact of Pharmaceutical Industry Messaging on the Opioid Crisis among U.S. Military Veterans | 000 | 2 | NIH | 2/9/2024 | $576,072 |
| 2024 | 2024 | NDRI-USA INC | 31 W 34TH ST | NEW YORK | NY | 10001-3009 | NEW YORK | USA | R01DA058016 | The Impact of Pharmaceutical Industry Messaging on the Opioid Crisis among U.S. Military Veterans | 001 | 2 | NIH | 4/25/2024 | $64,007 |
| 2024 | 2024 | NDRI-USA INC | 31 W 34TH ST | NEW YORK | NY | 10001-3009 | NEW YORK | USA | R01AA030975 | Looking through the bottle: Exploring alcohol use among emergency medical service providers | 000 | 2 | NIH | 6/21/2024 | $396,768 |
| 2024 | 2024 | NDRI-USA INC | 31 W 34TH ST | NEW YORK | NY | 10001-3009 | NEW YORK | USA | R01DA054990 | Community Developed Technology-Based Messaging to Increase SARS-CoV-2 Vaccine Uptake Among People Who Inject Drugs | 001 | 4 | NIH | 6/26/2024 | $461,653 |
| 2024 | 2024 | NDRI-USA INC | 31 W 34TH ST | NEW YORK | NY | 10001-3009 | NEW YORK | USA | R61DA059035 | Together Against Overdose: community developed technology to encourage drug checking, distribution of harm reduction supplies, and linkage to services | 000 | 1 | NIH | 9/16/2024 | $803,573 |
| 2024 | 2022 | NDRI-USA INC | 31 W 34TH ST | NEW YORK | NY | 10001-3009 | NEW YORK | USA | R21MD015136 | Health Determinants of Mental Health Disorders among Sexual and Gender Minority Firefighters | 000 | 2 | NIH | 8/15/2024 | -$6 |
|
| Issue Date FY: 2023 ( Subtotal = $1,071,284 ) |
| 2023 | 2023 | NDRI-USA INC | 31 W 34TH ST | NEW YORK | NY | 10001-3009 | NEW YORK | USA | R01AA030975 | Looking through the bottle: Exploring alcohol use among emergency medical service providers | 000 | 1 | NIH | 7/6/2023 | $399,326 |
| 2023 | 2023 | NDRI-USA INC | 31 W 34TH ST | NEW YORK | NY | 10001-3009 | NEW YORK | USA | R01DA058016 | The Impact of Pharmaceutical Industry Messaging on the Opioid Crisis among U.S. Military Veterans | 000 | 1 | NIH | 4/26/2023 | $671,958 |
|
| Issue Date FY: 2022 ( Subtotal = $166,500 ) |
| 2022 | 2022 | NDRI - USA, INC. | 31 W 34TH ST # 8006 | NEW YORK | NY | 10001-3009 | NEW YORK | USA | R21MD015136 | Health Determinants of Mental Health Disorders among Sexual and Gender Minority Firefighters | 001 | 2 | NIH | 5/2/2022 | $16,650 |
| 2022 | 2022 | NDRI - USA, INC. | 31 W 34TH ST # 8006 | NEW YORK | NY | 10001-3009 | NEW YORK | USA | R21MD015136 | Health Determinants of Mental Health Disorders among Sexual and Gender Minority Firefighters | 000 | 2 | NIH | 2/17/2022 | $149,850 |
|
| Issue Date FY: 2021 ( Subtotal = $367,783 ) |
| 2021 | 2021 | NDRI - USA, INC. | 31 W 34TH ST # 8006 | NEW YORK | NY | 10001-3009 | NEW YORK | USA | R21MD015136 | Health Determinants of Mental Health Disorders among Sexual and Gender Minority Firefighters | 000 | 1 | NIH | 4/16/2021 | $199,800 |
| 2021 | 2021 | NDRI - USA, INC. | 31 W 34TH ST # 8006 | NEW YORK | NY | 10001-3009 | NEW YORK | USA | R21DA046739 | Developing a public health measure of built environment to assess risk of nonmedical opioid use and related mortality in urban and non-urban areas in New Jersey | 000 | 2 | NIH | 3/26/2021 | $167,983 |
|
| Issue Date FY: 2020 ( Subtotal = $224,533 ) |
| 2020 | 2020 | NDRI - USA, INC. | 31 W 34TH ST # 8006 | NEW YORK | NY | 10001-3009 | NEW YORK | USA | R21DA046739 | Developing a public health measure of built environment to assess risk of nonmedical opioid use and related mortality in urban and non-urban areas in New Jersey | 000 | 1 | NIH | 4/7/2020 | $224,533 |
| 2020 | 2020 | NDRI - USA, INC. | 31 W 34TH ST # 8006 | NEW YORK | NY | 10001-3009 | NEW YORK | USA | R21DA046739 | Developing a public health measure of built environment to assess risk of nonmedical opioid use and related mortality in urban and non-urban areas in New Jersey | 001 | 1 | NIH | 4/10/2020 | $0 |
|
|